{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:33:00Z","timestamp":1780579980146,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["MH102215"],"award-info":[{"award-number":["MH102215"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["K23(DA034034-01A1)"],"award-info":[{"award-number":["K23(DA034034-01A1)"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11126-018-9621-4","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T07:58:01Z","timestamp":1547107081000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in Schizophrenia"],"prefix":"10.1007","volume":"90","author":[{"given":"Patrick A.","family":"Stolz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5555-5319","authenticated-orcid":false,"given":"Heidi J.","family":"Wehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"DiPaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna L.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"8","key":"9621_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.biopsych.2005.04.034","volume":"58","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Birnbaum H, Demler O, Falloon IR, Gagnon E, Guyer M, et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol Psychiatry. 2005;58(8):668\u201376.","journal-title":"Biol Psychiatry"},{"issue":"10100","key":"9621_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"12","key":"9621_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172\u201381.","journal-title":"JAMA Psychiat"},{"issue":"6","key":"9621_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1192\/bjp.171.6.502","volume":"171","author":"S Brown","year":"1997","unstructured":"Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171(6):502\u20138.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"9621_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115\u201321.","journal-title":"Am Heart J"},{"issue":"8_suppl","key":"9621_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1403494812457734","volume":"40","author":"F Diderichsen","year":"2012","unstructured":"Diderichsen F, Andersen I, Manuel C, Health WGotDRoSDo, Andersen A-MN, Bach E, et al. Health Inequality-determinants and policies. Scand J Public Health. 2012;40(8_suppl):12\u2013105.","journal-title":"Scand J Public Health"},{"issue":"2","key":"9621_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/YCO.0b013e32835035ca","volume":"25","author":"TM Laursen","year":"2012","unstructured":"Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25(2):83\u20138.","journal-title":"Curr Opin Psychiatry"},{"key":"9621_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425\u201348.","journal-title":"Annu Rev Clin Psychol"},{"issue":"12","key":"9621_CR9","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/070674371005501202","volume":"55","author":"D Lawrence","year":"2010","unstructured":"Lawrence D, Kisely S, Pais J. The epidemiology of excess mortality in people with mental illness. Can J Psychiatry. 2010;55(12):752\u201360.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"9621_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1192\/bjp.bp.109.076950","volume":"198","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell AJ, Lawrence D. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatry. 2011;198(6):434\u201341.","journal-title":"Br J Psychiatry"},{"issue":"9661","key":"9621_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0140-6736(08)61817-6","volume":"373","author":"G Thornicroft","year":"2009","unstructured":"Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M, Group IS. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet. 2009;373(9661):408\u201315.","journal-title":"Lancet"},{"key":"9621_CR12","unstructured":"Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry. 2007."},{"issue":"5","key":"9621_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1600-0447.2008.01163.x","volume":"117","author":"V Catts","year":"2008","unstructured":"Catts V, Catts S, O\u2019toole B, Frost A. Cancer incidence in patients with schizophrenia and their first-degree relatives\u2013a meta-analysis. Acta Psychiatr Scand. 2008;117(5):323\u201336.","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"9621_CR14","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","volume":"155","author":"GW Dalack","year":"1998","unstructured":"Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatr. 1998;155(11):1490\u2013501.","journal-title":"Am J Psychiatr"},{"key":"9621_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/schbul\/sbp152","volume":"37","author":"DL Kelly","year":"2011","unstructured":"Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37:832\u20138. https:\/\/doi.org\/10.1093\/schbul\/sbp152 .","journal-title":"Schizophr Bull"},{"issue":"5","key":"9621_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1753-6405.2008.00283.x","volume":"32","author":"K Moeller-Saxone","year":"2008","unstructured":"Moeller-Saxone K. Cigarette smoking and interest in quitting among consumers at a psychiatric disability rehabilitation and support Service in Victoria. Aust N Z J Public Health. 2008;32(5):479\u201381. https:\/\/doi.org\/10.1111\/j.1753-6405.2008.00283.x .","journal-title":"Aust N Z J Public Health"},{"issue":"2","key":"9621_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B Methodological. 1972;34(2):187\u2013220.","journal-title":"J R Stat Soc Ser B Methodological"},{"issue":"3","key":"9621_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/ajp.152.3.453","volume":"152","author":"J de Leon","year":"1995","unstructured":"de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995;152(3):453\u20135.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"9621_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4088\/JCP.v66n0205","volume":"66","author":"DC Goff","year":"2005","unstructured":"Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005;66(2):183\u201394 quiz 47, 273\u20134.","journal-title":"J Clin Psychiatry"},{"key":"9621_CR20","volume-title":"Deaths: final data for 2015","author":"SL Murphy","year":"2017","unstructured":"Murphy SL, Xu J, Kochanek KD, Curtin SC, Arias E. Deaths: final data for 2015. 2017."},{"key":"9621_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev.publhealth.25.102802.124406","volume":"25","author":"DK Hatsukami","year":"2004","unstructured":"Hatsukami DK, Henningfield JE, Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health. 2004;25:377\u201395.","journal-title":"Annu Rev Public Health"},{"key":"9621_CR22","doi-asserted-by":"publisher","unstructured":"Essali A, Al-Haj Haasan N, Li C, Rathbone J. Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database Syst Rev. 2009;1. https:\/\/doi.org\/10.1002\/14651858.CD000059.pub2 .","DOI":"10.1002\/14651858.CD000059.pub2"},{"issue":"3","key":"9621_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0165-1781(01)00234-7","volume":"101","author":"KR Fontaine","year":"2001","unstructured":"Fontaine KR, Heo M, Harrigan EP, Shear CL, Lakshminarayanan M, Casey DE, et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res. 2001;101(3):277\u201388.","journal-title":"Psychiatry Res"},{"issue":"3","key":"9621_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/schbul\/sbu120","volume":"41","author":"RD Hayes","year":"2014","unstructured":"Hayes RD, Downs J, Chang C-K, Jackson RG, Shetty H, Broadbent M, et al. The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. Schizophr Bull. 2014;41(3):644\u201355.","journal-title":"Schizophr Bull"},{"issue":"3","key":"9621_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4088\/JCP.08m04718yel","volume":"71","author":"DL Kelly","year":"2010","unstructured":"Kelly DL, McMahon RP, Liu F, Love RC, Wehring H, Shim JC, et al. Cardiovascular disease mortality in chronic schizophrenia patients treated with clozapine. J Clin Psychiatry. 2010;71(3):304\u201311.","journal-title":"J Clin Psychiatry"},{"issue":"9690","key":"9621_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620\u20137.","journal-title":"Lancet"},{"issue":"6","key":"9621_CR27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","volume":"8","author":"AM Walker","year":"1997","unstructured":"Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8(6):671\u20137.","journal-title":"Epidemiology"},{"issue":"7372","key":"9621_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","volume":"325","author":"S Hennessy","year":"2002","unstructured":"Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325(7372):1070.","journal-title":"BMJ"},{"key":"9621_CR29","unstructured":"Gelijns AC. Modern methods of clinical investigation: National Academies Press; 1990."},{"issue":"6","key":"9621_CR30","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/0149-2918(95)80085-9","volume":"17","author":"JA Staffa","year":"1995","unstructured":"Staffa JA, Jones JK, Gable CB, Verspeelt JP, Amery WK. Risk of selected serious cardiac events among new users of antihistamines. Clin Ther. 1995;17(6):1062\u201377.","journal-title":"Clin Ther"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-018-9621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-018-9621-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-018-9621-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T23:02:18Z","timestamp":1720911738000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-018-9621-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["9621"],"URL":"https:\/\/doi.org\/10.1007\/s11126-018-9621-4","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"10 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Deanna L. Kelly: Advisory board for Lundbeck and a consultant for HLS Therapeutics.Raymond C. Love: Speaking fee for Nevada Psychiatric Association, received honorarium for Advisory Board on Pharmacist Administration of Medication, and is part of the National Alliance of State Pharmacy Association.All other authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed were done so in accordance with the ethical standards of the University of Maryland and Maryland Department of Health Institutional Review Boards and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"A waiver of informed consent was approved by the University of Maryland-Baltimore and the Maryland Department of Health Institutional Review Boards for this retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}